{"component": "definition", "props": {"groups": [{"size": 179, "snippet": "means, with respect to the Compounds, all submissions to Regulatory Authorities in connection with the development of such Compounds, including all INDs and amendments thereto, NDAs and amendments thereto, drug master files, correspondence with regulatory agencies, periodic safety update reports, adverse event files, complaint files, inspection reports and manufacturing records, in each case together with all supporting documents (including documents that include Clinical Data).", "samples": [{"hash": "ddBiVLKu9i2", "uri": "/contracts/ddBiVLKu9i2#regulatory-documentation", "label": "Clinical Trial Collaboration and Supply Agreement (Shattuck Labs, Inc.)", "score": 34.1444206238, "published": true}, {"hash": "ljaEN1aTlqH", "uri": "/contracts/ljaEN1aTlqH#regulatory-documentation", "label": "Clinical Trial Collaboration and Supply Agreement (BioLineRx Ltd.)", "score": 33.2026023865, "published": true}, {"hash": "eKzqWUimtdb", "uri": "/contracts/eKzqWUimtdb#regulatory-documentation", "label": "Clinical Trial Collaboration and Supply Agreement (Intensity Therapeutics, Inc.)", "score": 32.8220405579, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "submissions-to-regulatory-authorities", "type": "clause", "offset": [42, 79]}, {"key": "in-connection-with", "type": "clause", "offset": [80, 98]}, {"key": "development-of", "type": "clause", "offset": [103, 117]}, {"key": "and-amendments", "type": "clause", "offset": [153, 167]}, {"key": "drug-master-files", "type": "clause", "offset": [206, 223]}, {"key": "regulatory-agencies", "type": "definition", "offset": [245, 264]}, {"key": "update-reports", "type": "clause", "offset": [282, 296]}, {"key": "adverse-event", "type": "clause", "offset": [298, 311]}, {"key": "complaint-files", "type": "clause", "offset": [319, 334]}, {"key": "inspection-reports", "type": "definition", "offset": [336, 354]}, {"key": "manufacturing-records", "type": "clause", "offset": [359, 380]}, {"key": "each-case", "type": "definition", "offset": [385, 394]}, {"key": "supporting-documents", "type": "definition", "offset": [413, 433]}, {"key": "clinical-data", "type": "definition", "offset": [468, 481]}], "hash": "cf3f490eea73dd65ee0d37c38c46a22b", "id": 1}, {"size": 45, "snippet": "means: all (i) applications (including all INDs and Drug Approval Applications), registrations, licenses, authorizations and approvals (including Regulatory Approvals); (ii) correspondence and reports submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents with respect thereto, including all adverse event files and complaint files; and (iii) clinical and other data contained or relied upon in any of the foregoing; in each case ((i), (ii) and (iii)) relating to the Licensed Compound or a Licensed Product.", "samples": [{"hash": "fqM9ElDVwT4", "uri": "/contracts/fqM9ElDVwT4#regulatory-documentation", "label": "Collaboration Agreement (Eikon Therapeutics, Inc.)", "score": 37.0219039917, "published": true}, {"hash": "12buAtZngE9", "uri": "/contracts/12buAtZngE9#regulatory-documentation", "label": "Collaboration Agreement (Eikon Therapeutics, Inc.)", "score": 36.7344284058, "published": true}, {"hash": "4ABLghGl7jn", "uri": "/contracts/4ABLghGl7jn#regulatory-documentation", "label": "Collaboration Agreement (Eikon Therapeutics, Inc.)", "score": 36.4962348938, "published": true}], "snippet_links": [{"key": "inds-and-drug-approval-applications", "type": "clause", "offset": [43, 78]}, {"key": "authorizations-and-approvals", "type": "clause", "offset": [106, 134]}, {"key": "regulatory-approvals", "type": "definition", "offset": [146, 166]}, {"key": "regulatory-authorities", "type": "clause", "offset": [231, 253]}, {"key": "contact-reports", "type": "clause", "offset": [286, 301]}, {"key": "relating-to", "type": "definition", "offset": [302, 313]}, {"key": "regulatory-authority", "type": "clause", "offset": [342, 362]}, {"key": "supporting-documents", "type": "definition", "offset": [372, 392]}, {"key": "adverse-event", "type": "clause", "offset": [429, 442]}, {"key": "complaint-files", "type": "clause", "offset": [453, 468]}, {"key": "other-data", "type": "definition", "offset": [493, 503]}, {"key": "the-foregoing", "type": "clause", "offset": [539, 552]}, {"key": "each-case", "type": "definition", "offset": [557, 566]}, {"key": "licensed-compound", "type": "definition", "offset": [605, 622]}, {"key": "licensed-product", "type": "definition", "offset": [628, 644]}], "hash": "219c984c070a5877201e1c7342319e58", "id": 2}, {"size": 42, "snippet": "means all (a) applications (including all INDs and Drug Approval Applications), registrations, licenses, authorizations and approvals (including all Market Approvals), (b) correspondence and reports submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents with respect thereto, including all regulatory drug lists, advertising and promotion documents, Adverse Event files and complaint files and (c) Clinical Data and any other data contained in any of the foregoing, in each case ((a), (b) and (c)), relating to the Licensed Product.", "samples": [{"hash": "eSONFzjGTpk", "uri": "/contracts/eSONFzjGTpk#regulatory-documentation", "label": "Joint Development and License Agreement (Alto Neuroscience, Inc.)", "score": 34.9876785278, "published": true}, {"hash": "62UigPmAr3u", "uri": "/contracts/62UigPmAr3u#regulatory-documentation", "label": "License Agreement (Alto Neuroscience, Inc.)", "score": 34.9876785278, "published": true}, {"hash": "bBYqzLN0Hib", "uri": "/contracts/bBYqzLN0Hib#regulatory-documentation", "label": "License Agreement (First Wave BioPharma, Inc.)", "score": 34.7713890076, "published": true}], "snippet_links": [{"key": "inds-and-drug-approval-applications", "type": "clause", "offset": [42, 77]}, {"key": "authorizations-and-approvals", "type": "clause", "offset": [105, 133]}, {"key": "regulatory-authorities", "type": "clause", "offset": [229, 251]}, {"key": "contact-reports", "type": "clause", "offset": [284, 299]}, {"key": "relating-to", "type": "definition", "offset": [300, 311]}, {"key": "regulatory-authority", "type": "clause", "offset": [340, 360]}, {"key": "supporting-documents", "type": "definition", "offset": [370, 390]}, {"key": "advertising-and-promotion", "type": "clause", "offset": [450, 475]}, {"key": "adverse-event", "type": "clause", "offset": [487, 500]}, {"key": "complaint-files", "type": "clause", "offset": [511, 526]}, {"key": "clinical-data", "type": "definition", "offset": [535, 548]}, {"key": "other-data", "type": "definition", "offset": [557, 567]}, {"key": "contained-in", "type": "definition", "offset": [568, 580]}, {"key": "the-foregoing", "type": "clause", "offset": [588, 601]}, {"key": "each-case", "type": "definition", "offset": [606, 615]}, {"key": "licensed-product", "type": "definition", "offset": [652, 668]}], "hash": "4ab0ef6c666adc3eb6078319a295bc1c", "id": 3}, {"size": 40, "snippet": "means all applications, registrations, licenses, authorizations and approvals, all correspondence submitted to or received from Regulatory Authorities (including Registration Dossiers, minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents, in each case relating to the Licensed Product, and all data contained in any of the foregoing, including all clinical trial applications, Regulatory Approvals and applications therefor, regulatory drug lists, advertising and promotion documents, adverse event files and complaint files.", "samples": [{"hash": "3gKXIRn9bgE", "uri": "/contracts/3gKXIRn9bgE#regulatory-documentation", "label": "License and Collaboration Agreement (Esperion Therapeutics, Inc.)", "score": 31.6064338684, "published": true}, {"hash": "j28QZP8Qksc", "uri": "https://investor.esperion.com/static-files/afe1e128-d0a2-4455-b75c-128c4750fd79", "label": "investor.esperion.com", "score": 10.3032169342, "published": false}], "snippet_links": [{"key": "authorizations-and-approvals", "type": "clause", "offset": [49, 77]}, {"key": "regulatory-authorities", "type": "clause", "offset": [128, 150]}, {"key": "registration-dossiers", "type": "definition", "offset": [162, 183]}, {"key": "contact-reports", "type": "clause", "offset": [206, 221]}, {"key": "relating-to", "type": "definition", "offset": [222, 233]}, {"key": "regulatory-authority", "type": "clause", "offset": [262, 282]}, {"key": "supporting-documents", "type": "definition", "offset": [292, 312]}, {"key": "each-case", "type": "definition", "offset": [317, 326]}, {"key": "licensed-product", "type": "definition", "offset": [343, 359]}, {"key": "contained-in", "type": "definition", "offset": [374, 386]}, {"key": "the-foregoing", "type": "clause", "offset": [394, 407]}, {"key": "clinical-trial", "type": "clause", "offset": [423, 437]}, {"key": "regulatory-approvals-and-applications", "type": "clause", "offset": [452, 489]}, {"key": "advertising-and-promotion", "type": "clause", "offset": [523, 548]}, {"key": "adverse-event", "type": "clause", "offset": [560, 573]}, {"key": "complaint-files", "type": "clause", "offset": [584, 599]}], "hash": "e14632734682d5377fd06196c9f3e383", "id": 4}, {"size": 37, "snippet": "means any and all (a) applications, registrations, licenses, authorizations and approvals (including Regulatory Approvals); and (b) correspondence, reports and other submissions submitted to or received from Regulatory Authorities and all supporting documents with respect thereto, including all adverse event files and complaint files.", "samples": [{"hash": "hpZqCTuqu3Z", "uri": "/contracts/hpZqCTuqu3Z#regulatory-documentation", "label": "Commercialization Agreement (Beta Bionics, Inc)", "score": 36.0143737793, "published": true}, {"hash": "dZT9m0aWUGA", "uri": "/contracts/dZT9m0aWUGA#regulatory-documentation", "label": "Commercialization Agreement (Beta Bionics, Inc)", "score": 35.9568786621, "published": true}, {"hash": "bCFreVHni8g", "uri": "/contracts/bCFreVHni8g#regulatory-documentation", "label": "Commercialization Agreement (Beta Bionics, Inc)", "score": 35.8227233887, "published": true}], "snippet_links": [{"key": "authorizations-and-approvals", "type": "clause", "offset": [61, 89]}, {"key": "regulatory-approvals", "type": "definition", "offset": [101, 121]}, {"key": "other-submissions", "type": "clause", "offset": [160, 177]}, {"key": "regulatory-authorities", "type": "clause", "offset": [208, 230]}, {"key": "supporting-documents", "type": "definition", "offset": [239, 259]}, {"key": "adverse-event", "type": "clause", "offset": [296, 309]}, {"key": "complaint-files", "type": "clause", "offset": [320, 335]}], "hash": "f5e409260345f63f88df2251de0d7415", "id": 5}, {"size": 35, "snippet": "means all (i) applications (including all INDs and Drug Approval Applications), registrations, licenses, authorizations, and approvals (including Regulatory Approvals); (ii) correspondence and reports submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents with respect thereto, including all regulatory drug lists, advertising and promotion documents, adverse event files, and complaint files; and (iii) clinical and other data contained or relied upon in any of the foregoing, in each case ((i), (ii), and (iii)) relating to a Product.", "samples": [{"hash": "1SbIHWop23B", "uri": "/contracts/1SbIHWop23B#regulatory-documentation", "label": "License Agreement (Point of Care Nano-Technology, Inc.)", "score": 35.4394264221, "published": true}, {"hash": "8sIYHADQohi", "uri": "/contracts/8sIYHADQohi#regulatory-documentation", "label": "License Agreement (Emergent BioSolutions Inc.)", "score": 30.1416835785, "published": true}, {"hash": "3JerXTLerfd", "uri": "/contracts/3JerXTLerfd#regulatory-documentation", "label": "License Agreement (Opiant Pharmaceuticals, Inc.)", "score": 29.1724853516, "published": true}], "snippet_links": [{"key": "inds-and-drug-approval-applications", "type": "clause", "offset": [42, 77]}, {"key": "regulatory-approvals", "type": "definition", "offset": [146, 166]}, {"key": "regulatory-authorities", "type": "clause", "offset": [231, 253]}, {"key": "contact-reports", "type": "clause", "offset": [286, 301]}, {"key": "relating-to", "type": "definition", "offset": [302, 313]}, {"key": "regulatory-authority", "type": "clause", "offset": [342, 362]}, {"key": "supporting-documents", "type": "definition", "offset": [372, 392]}, {"key": "advertising-and-promotion", "type": "clause", "offset": [452, 477]}, {"key": "adverse-event", "type": "clause", "offset": [489, 502]}, {"key": "complaint-files", "type": "clause", "offset": [514, 529]}, {"key": "other-data", "type": "definition", "offset": [554, 564]}, {"key": "the-foregoing", "type": "clause", "offset": [600, 613]}, {"key": "each-case", "type": "definition", "offset": [618, 627]}], "hash": "9cd7384bcf96d36cddc74fdec249ecc3", "id": 6}, {"size": 27, "snippet": "means all applications, registrations, licenses, authorizations and approvals (including all Regulatory Approvals), all correspondence submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority), all supporting documents and all clinical studies and tests, including the manufacturing batch records, relating to the Product, and all data contained in any of the foregoing, including all regulatory drug lists, advertising and promotion documents, adverse event files and complaint files.", "samples": [{"hash": "kw4pbGlknFt", "uri": "/contracts/kw4pbGlknFt#regulatory-documentation", "label": "License Agreement (Isis Pharmaceuticals Inc)", "score": 21.0, "published": true}, {"hash": "kYnOyh52Jb2", "uri": "/contracts/kYnOyh52Jb2#regulatory-documentation", "label": "Collaboration and Co Development Agreement (Oncogenex Technologies Inc)", "score": 21.0, "published": true}, {"hash": "jTjSIeGcG9J", "uri": "/contracts/jTjSIeGcG9J#regulatory-documentation", "label": "Collaboration and License Agreement (Oncogenex Technologies Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "authorizations-and-approvals", "type": "clause", "offset": [49, 77]}, {"key": "regulatory-approvals", "type": "definition", "offset": [93, 113]}, {"key": "regulatory-authorities", "type": "clause", "offset": [165, 187]}, {"key": "contact-reports", "type": "clause", "offset": [220, 235]}, {"key": "relating-to", "type": "definition", "offset": [236, 247]}, {"key": "regulatory-authority", "type": "clause", "offset": [276, 296]}, {"key": "supporting-documents", "type": "definition", "offset": [303, 323]}, {"key": "studies-and-tests", "type": "clause", "offset": [341, 358]}, {"key": "manufacturing-batch-records", "type": "clause", "offset": [374, 401]}, {"key": "the-product", "type": "clause", "offset": [415, 426]}, {"key": "contained-in", "type": "definition", "offset": [441, 453]}, {"key": "the-foregoing", "type": "clause", "offset": [461, 474]}, {"key": "advertising-and-promotion", "type": "clause", "offset": [513, 538]}, {"key": "adverse-event", "type": "clause", "offset": [550, 563]}, {"key": "complaint-files", "type": "clause", "offset": [574, 589]}], "hash": "2088c6c48de7a6d37efd4160ef57de84", "id": 7}, {"size": 21, "snippet": "means all applications, registrations, licenses, authorizations and approvals, all correspondence submitted to or received from Regulatory Health Authorities (including minutes and official contact reports relating to any communications with any Regulatory Health Authority) and all supporting documents, including documentation arising in the course of all clinical studies and tests, in each case relating to any Program Compounds or Program Products, including all INDs, Regulatory Approvals, regulatory drug lists, advertising and promotion documents, adverse event files and complaint files.", "samples": [{"hash": "jKFraRng5JU", "uri": "/contracts/jKFraRng5JU#regulatory-documentation", "label": "License Agreement (Ardelyx, Inc.)", "score": 25.4243659973, "published": true}, {"hash": "HjNqQ1ZvHq", "uri": "/contracts/HjNqQ1ZvHq#regulatory-documentation", "label": "License Agreement (Ardelyx, Inc.)", "score": 25.377822876, "published": true}, {"hash": "fpSnyR4Gu2N", "uri": "/contracts/fpSnyR4Gu2N#regulatory-documentation", "label": "License Agreement (Ardelyx, Inc.)", "score": 25.2737846375, "published": true}], "snippet_links": [{"key": "authorizations-and-approvals", "type": "clause", "offset": [49, 77]}, {"key": "health-authorities", "type": "definition", "offset": [139, 157]}, {"key": "contact-reports", "type": "clause", "offset": [190, 205]}, {"key": "relating-to", "type": "definition", "offset": [206, 217]}, {"key": "regulatory-health-authority", "type": "definition", "offset": [246, 273]}, {"key": "supporting-documents", "type": "definition", "offset": [283, 303]}, {"key": "in-the-course-of", "type": "definition", "offset": [337, 353]}, {"key": "studies-and-tests", "type": "clause", "offset": [367, 384]}, {"key": "each-case", "type": "definition", "offset": [389, 398]}, {"key": "program-compounds", "type": "definition", "offset": [415, 432]}, {"key": "program-products", "type": "definition", "offset": [436, 452]}, {"key": "regulatory-approvals", "type": "definition", "offset": [474, 494]}, {"key": "advertising-and-promotion", "type": "clause", "offset": [519, 544]}, {"key": "adverse-event", "type": "clause", "offset": [556, 569]}, {"key": "complaint-files", "type": "clause", "offset": [580, 595]}], "hash": "c3e55c6fa89a14622010b1586f2181ff", "id": 8}, {"size": 20, "snippet": "means all (a) applications (including all INDs and Drug Approval Applications and other regulatory filings), registrations, licenses, authorizations, and approvals (including Regulatory Approvals); (b) correspondence and reports submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority) and all supporting documents with respect thereto, including all regulatory drug lists, advertising and promotion documents, adverse event files, and complaint files; and (c) pre-clinical and clinical data, and data contained or relied upon in any of the foregoing, in each case (a), (b), and (c) relating to Product.", "samples": [{"hash": "7WnTaLKXFQE", "uri": "/contracts/7WnTaLKXFQE#regulatory-documentation", "label": "Early Access Agreement (Hemispherx Biopharma Inc)", "score": 28.3483905792, "published": true}, {"hash": "57Y6mJWnU88", "uri": "/contracts/57Y6mJWnU88#regulatory-documentation", "label": "Early Access Agreement (Hemispherx Biopharma Inc)", "score": 28.0444908142, "published": true}, {"hash": "bDsRuCCF1Yb", "uri": "/contracts/bDsRuCCF1Yb#regulatory-documentation", "label": "Early Access Agreement (Hemispherx Biopharma Inc)", "score": 26.8726902008, "published": true}], "snippet_links": [{"key": "inds-and-drug-approval-applications", "type": "clause", "offset": [42, 77]}, {"key": "other-regulatory-filings", "type": "clause", "offset": [82, 106]}, {"key": "regulatory-approvals", "type": "definition", "offset": [175, 195]}, {"key": "regulatory-authorities", "type": "clause", "offset": [259, 281]}, {"key": "contact-reports", "type": "clause", "offset": [314, 329]}, {"key": "relating-to", "type": "definition", "offset": [330, 341]}, {"key": "regulatory-authority", "type": "clause", "offset": [370, 390]}, {"key": "supporting-documents", "type": "definition", "offset": [400, 420]}, {"key": "advertising-and-promotion", "type": "clause", "offset": [480, 505]}, {"key": "adverse-event", "type": "clause", "offset": [517, 530]}, {"key": "complaint-files", "type": "clause", "offset": [542, 557]}, {"key": "clinical-data", "type": "definition", "offset": [584, 597]}, {"key": "the-foregoing", "type": "clause", "offset": [643, 656]}, {"key": "each-case", "type": "definition", "offset": [661, 670]}], "hash": "fbe2b855c70d075304aa219b99de9e0b", "id": 9}, {"size": 17, "snippet": "means, with respect to a Licensed Product, all Regulatory Filings and supporting documents created, submitted to a Regulatory Authority, and all data contained therein, including, without limitation, any Investigational New Drug Application, New Drug Application, Marketing Authorization Application, foreign counterparts thereof, Investigator\u2019s Brochures, drug master files, correspondence to and from a Regulatory Authority, minutes from teleconferences with Regulatory Authorities, registrations and licenses, regulatory drug lists, advertising and promotion documents shared with Regulatory Authorities, adverse event files, complaint files and manufacturing records.", "samples": [{"hash": "iy1jiXgQRDs", "uri": "/contracts/iy1jiXgQRDs#regulatory-documentation", "label": "H1n1 License Agreement (Novavax Inc)", "score": 21.2026004791, "published": true}, {"hash": "k6f5r6D0dfc", "uri": "/contracts/k6f5r6D0dfc#regulatory-documentation", "label": "Seasonal / Other License Agreement (Novavax Inc)", "score": 21.0, "published": true}, {"hash": "7qud2t0H0y5", "uri": "/contracts/7qud2t0H0y5#regulatory-documentation", "label": "Option Agreement (Novavax Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "licensed-product", "type": "definition", "offset": [25, 41]}, {"key": "regulatory-filings", "type": "clause", "offset": [47, 65]}, {"key": "supporting-documents", "type": "definition", "offset": [70, 90]}, {"key": "regulatory-authority", "type": "clause", "offset": [115, 135]}, {"key": "without-limitation", "type": "clause", "offset": [180, 198]}, {"key": "investigational-new-drug-application", "type": "clause", "offset": [204, 240]}, {"key": "marketing-authorization-application", "type": "definition", "offset": [264, 299]}, {"key": "foreign-counterparts", "type": "definition", "offset": [301, 321]}, {"key": "drug-master-files", "type": "clause", "offset": [357, 374]}, {"key": "correspondence-to", "type": "clause", "offset": [376, 393]}, {"key": "regulatory-authorities", "type": "clause", "offset": [461, 483]}, {"key": "registrations-and-licenses", "type": "clause", "offset": [485, 511]}, {"key": "advertising-and-promotion", "type": "clause", "offset": [536, 561]}, {"key": "adverse-event", "type": "clause", "offset": [608, 621]}, {"key": "complaint-files", "type": "clause", "offset": [629, 644]}, {"key": "manufacturing-records", "type": "clause", "offset": [649, 670]}], "hash": "cc13f0c2950fd4c019971debbe3dc36c", "id": 10}], "next_curs": "CmUSX2oVc35sYXdpbnNpZGVyY29udHJhY3RzckELEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIhcmVndWxhdG9yeS1kb2N1bWVudGF0aW9uIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Regulatory Documentation", "size": 1326, "snippet": "means, with respect to the Compounds, all submissions to Regulatory Authorities in connection with the development of such Compounds, including all INDs and amendments thereto, NDAs and amendments thereto, drug master files, correspondence with regulatory agencies, periodic safety update reports, adverse event files, complaint files, inspection reports and manufacturing records, in each case together with all supporting documents (including documents that include Clinical Data).", "id": "regulatory-documentation", "examples": ["Licensee, its Affiliates and its sublicensees shall have a right of reference to the <strong>Regulatory Documentation</strong> for Lasofoxifene controlled by Ligand, its Affiliates and/or its sublicensees, to rely upon, and otherwise use, an investigation for the purpose of obtaining approval of an application for a Product in the Field in the Territory, including the ability to make available the underlying raw data in its possession in documented or electronic form from the investigation for FDA audit, if necessary.", "Ligand acknowledges and agrees that Sermonix has or will disclose and provide to Licensee all tangible embodiments of data and information concerning the Licensed Technology and <strong>Regulatory Documentation</strong> (including without limitation all safety data for the Product) that is in Sermonix\u2019s possession as of the Effective Date and was disclosed and provided to Sermonix by Ligand pursuant to the Original Agreement."], "related": [["regulatory-documents", "Regulatory Documents", "Regulatory Documents"], ["regulatory-materials", "Regulatory Materials", "Regulatory Materials"], ["regulatory-filing", "Regulatory Filing", "Regulatory Filing"], ["regulatory-filings", "Regulatory Filings", "Regulatory Filings"], ["regulatory-data", "Regulatory Data", "Regulatory Data"]], "related_snippets": [], "updated": "2026-04-24T04:48:06+00:00"}, "json": true, "cursor": ""}}